🇺🇸 FDA
Patent

US 7871775

Compositions and methods for the identification, assessment, prevention and therapy of human cancers

granted A61PA61P35/00

Quick answer

US patent 7871775 (Compositions and methods for the identification, assessment, prevention and therapy of human cancers) held by The Board of Regents of the University of Texas System expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00